Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Скринер
Новости
О нас

ARAY - Accuray Incorporated Последние новости | Finranks

Home

/

ARAY

A

Accuray Incorporated (ARAY)

NMS – Цена в реальном времени. Валюта: USD

0.26

-0.05 (-16.58%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

0.27

+0.01 (2.42%)

После закрытия: Jun 26, 2026, 7:57 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform.

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

Accuray Reports Fiscal 2026 Third Quarter Financial Results

Accuray Reports Fiscal 2026 Third Quarter Financial Results

MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026.

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m.

Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026.

Accuray Incorporated (ARAY) Q2 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q2 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q2 2026 Earnings Call Transcript

Видео

No Data

There is no data to display

Пресс-релизы

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform.

Accuray Reports Fiscal 2026 Third Quarter Financial Results

Accuray Reports Fiscal 2026 Third Quarter Financial Results

MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026.

Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026.